Story · Medicine & Biotech

Eisai to unveil five-year Alzheimer’s drug data at CTAD 2026

1 outlet · first reported by Longevity.Technology 12d ago

Coverage, in order

  1. 12d ago
    Longevity.Technology UK indie
    Eisai to unveil five-year Alzheimer’s drug data at CTAD 2026

    Eisai will present new five-year data for lecanemab and multiple real-world studies at the 19th Clinical Trials on Alzheimer’s Disease conference, 16-19 Nov. 2026, in Boston and online. Highlights include five-year treatment findings from the Clarity AD core and long-term extension phases and…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.